Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer

Decera Clinical Education Oncology Podcast · Apr 6, 2022 · 21m

In this episode, Nilofer S. Azad, MD, and Kanwal Raghav, MD, discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients with mCRC, with topics including:

Current use of regorafenib and TAS-102 monotherapy

Combination therapy with regorafenib and PD-1 inhibitors

Adding bevacizumab to TAS-102

Presenters:

Nilofer S. Azad, MD

Professor, Oncology

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Baltimore, Maryland

Kanwal Raghav, MD

Associate Professor, GI Medical Oncology

University of Texas MD Anderson Cancer Center

Houston, Texas

Content…